MTOR and diffuse large B-cell lymphoma: We demonstrated that AGN inhibits cell viability in three DLBCL cell lines (Ly1, Ly10, and DHL6) through the activation of caspase 3/7 by downregulating PI3K/AKT/mTOR and MAPK pathways (Figs 1 and 2).